Timothy Springer
Venture Capital
Timothy A. Springer is an immunologist, biochemist, and Latham Family Professor at Harvard Medical School, renowned for discovering the first integrins (LFA-1) and intercellular adhesion molecules. He is a serial biotech entrepreneur and one of the most prolific angel investors in the life sciences, best known as a founding investor of Moderna where his $5M investment in 2010 returned over $400M at IPO in 2018.
Boston, United States · 2+ investments
Seed
Early Stage
Growth
Biotech
Life Sciences
drug_discovery
immunology
protein_therapeutics
- Headquarters
- Boston, United States
- Website
- timothyspringer.org
- Total Investments
- 2
- Last Investment
- Jan 2018
- Geographic Focus
- United States
Investment Thesis
Invests in early-stage life sciences and biotech companies, translating academic scientific insights into therapeutic ventures. Focuses on immunology, cell adhesion biology, protein engineering, oncology, and rare diseases. Favors companies where deep scientific innovation creates a foundation for multiple FDA-approved drugs. Participates from founding or very early rounds, often in companies he co-founds or where he has a scientific role.
Timothy Springer is a Venture Capital firm based in Boston, United States. It has made 2 investments in Biotech and Life Sciences.
Investment History
Sign up to view investment history
Create a free account — 25 credits a month to unlock deal history, amounts, and round details.